From Data to Decisions: Cell and Gene Therapy Trends and Developments Webcast

This session will examine expectations versus real-world experience for cell and gene therapies (CGTs), including costs, uptake, and risk. We will share insights from claims data and manufacturer revenue analyses, and discuss the impact of the FDA’s expedited approval pathways and what this may mean for forecasting future exposure. The session will also explore the implications of CGTs for various stakeholders and describe risk-mitigation solutions available today. Attendees will gain actionable insights to help actuaries navigate the evolving landscape of cell and gene therapies.

We highly recommend registering at least one day in advance of the webcast to ensure you receive the access instructions. A confirmation with access instructions is provided shortly after registering, along with a reminder the day before and 1 hour before the webcast. If you do not receive instructions to access the webcast, please email pd@soa.org.

Please note that attendees may not record this meeting or use unauthorized recording or automated meeting tools, including AI note-taking assistants, recording bots, and similar technologies, unless expressly authorized by the event organizer. Registrants should not invite, authorize, or otherwise enable these tools to join on their behalf. Attendance is limited to registered participants only.

Participants who require assistive technology as a reasonable accommodation should contact the event organizer in advance so appropriate arrangements can be made.

Webcast Pricing

Our standard webcast pricing is the convenient way to access a single SOA webcast. Visit the webcast registration information page for details.